All Transactions - Bryan, Garnier & Co

Our transactions

Bryan, Garnier & Co offers a complete range of investment banking services, from growth financing to mergers and acquisitions.

Bryan, Garnier & Co acts as European Lead Manager to Humanigen on its USD 92.5 million Marketed Follow-on Offering

Bryan, Garnier & Co acts as Joint Global Coordinator & Joint Bookrunner to LMK Group on its SEK 500 million Initial Public Offering

LMK_Group_website_tombstone

Bryan, Garnier & Co acts as Joint Global Coordinator and Joint Bookrunner to GenSight on its EUR 30 million Follow-on Offering

GenSight_2021_website_tombstone

Bryan, Garnier & Co acts as Joint Bookrunner to Azelio on its SEK 596 million Follow-on Offering

Azelio_website_tombstone_march2021

Bryan, Garnier & Co acts as Sole Financial Advisor to Medisys on its merger with Cityzen

Medisys_website_tombstone

Bryan, Garnier & Co acts as Sole Financial Advisor to Metsys on its growth financing led by European Digital Group

Metsys_tombstone_2

Bryan, Garnier & Co acts as Joint Global Coordinator and Joint Bookrunner to Basilea Pharmaceutica on its CHF 46 million Follow-on Offering

Bryan, Garnier & Co acts as Sole Financial Advisor to the shareholders of Ginolis Ltd on the sale of the company to Cellink AB

Ginolis_website_tombstone

Bryan, Garnier & Co acts as Sole Financial Advisor to the Sellers of Radon Creative to Valtech

Radon_Creative_tombstone

Bryan, Garnier & Co acts as Joint Global Coordinator and Joint Bookrunner to MedinCell on its EUR 30 million Follow-on Offering

Medincell_website_tombstone

Bryan, Garnier & Co acts as Sole Financial Advisor to TA Associates on its majority growth investment in DL Software

DL_Software_tombstone

Bryan, Garnier & Co helps Zealand Pharma raise DKK 749 million from the global capital markets via an accelerated bookbuild

Zealand_Pharma_tombstone

Bryan, Garnier & Co acts as Sole Financial Advisor to the shareholders of Martha Flora on the sale of minority stake to DomusVi

Martha_flora_tombstone

Bryan, Garnier & Co acts as Sole Financial Advisor to the shareholders of BioBag in the sale of the company to Novamont

BioBag_website_tombstone

Bryan, Garnier & Co acts as Sole Financial Advisor to Lifco on its acquisition of ContacEZ

Lifco_website_tombstone

Bryan, Garnier & Co acts as Sole Financial Advisor to the founders and shareholders of TagPay on Long Arc Capital’s investment

TagPay_website_tombstone

Bryan, Garnier & Co acts as Sole Financial Advisor and Placement Agent to asgoodasnew, the German circular economy pioneer, on its EUR 18 million Series C private placement

asgoodasnew_website_tombstone_2

Bryan, Garnier & Co acts as Joint Global Coordinator and Joint Bookrunner to Nicox on its EUR 15 million Follow-on Offering

Nicox_website_tombstone

Bryan, Garnier & Co acts as Sole Financial Advisor to Calliditas Therapeutics on its acquisition of Genkyotex for €88 million

Calliditas_website_tombstone

Bryan, Garnier & Co acts as Sole Financial Advisor and Sole Placement Agent to leading European cybersecurity company EclecticIQ on its EUR 20 million Series C capital raise led by Ace Management (a Tikehau Capital company)

EclecticlQ_website_tombstone_3

Bryan, Garnier & Co acts as Financial Advisor in Apax Partners’ investment in Diapason

Diapason_website_tombstone

Bryan, Garnier & Co acts as Sole Financial Advisor to the shareholders of Specim on the sale of the company to Konica Minolta

Bryan, Garnier & Co acts as Sole Global Coordinator and Sole Bookrunner to Proparco on its EUR 23 million Secondary Offering of Voltalia shares

Voltalia_website_tombstone

Bryan, Garnier & Co acts as Sole Financial Advisor to IT services group Artemys and its founders on a minority LBO operation with Andera Partners

Artemys_website_tombstone

Bryan, Garnier & Co acts as Sole Financial Advisor to Amplexor International on the disposal of its France-based digital document engineering business unit, Amplexor Business Services, to Hivest Capital Partners

Amplexor_website_tombstone

Bryan, Garnier & Co acts as Sole Global Coordinator and Sole Bookrunner to Abivax on its EUR 28 million Follow-on Offering

Abivax_website_tombstone

Bryan, Garnier & Co acts as Joint Bookrunner to GenSight on its EUR 25 million Follow-on Offering

Tombstone_gensight

Bryan, Garnier & Co acts as Joint Bookrunner to Targovax on its NOK 75 million Follow-on Offering

Bryan, Garnier & Co acts as Sole Financial Advisor, Sole Global Coordinator and Sole Bookrunner to McPhy on a EUR 180m Follow-on Offering including Strategic Investments from Chart Industries and Technip Energies

McPhy_website_tombstone_4

Bryan, Garnier & Co acts as Sole Financial Advisor to INNOTHERA Group on its acquisition of Gibaud

Innothera_website_tombstone

Bryan, Garnier & Co acts as Sole Financial Advisor to Sword Group SE on the disposal of its French unit, Sword France, to Argos Wityu

tombstone_sword_argos

Bryan, Garnier & Co acts as Sole Financial Advisor to EasyVista (Euronext: ALEZV) on a contemplated take-private led by Eurazeo PME

EasyVista_2_website_tombstone

Bryan, Garnier & Co acts as Joint Bookrunner on Sensorion’s EUR 31 million Follow-on Offering with top tier US and European biotech specialists and institutional investors

website_tombstone_2

Bryan, Garnier & Co acts as European Lead Manager to Humanigen on its USD 78 million Follow-on Offering

tombstone_humanigen_78200000_dollars

Bryan, Garnier & Co acts as Joint Bookrunner to Azelio on its SEK 270 million Follow-on Offering

Azelio tombstone 2

Bryan, Garnier & Co acts as Sole Financial Advisor to the shareholders of Innovasjon on the sale of the company to Visolit

Innovasjon_AS_website_tombstone

Bryan, Garnier & Co acts as Co-manager to BioNTech on its USD511.5 million upsized Publicly-marketed Follow-on Offering

BioNTech_website_tombstone

Bryan, Garnier & Co acts as Joint Global Coordinator and Joint Bookrunner to Carbios on its EUR 37 million upsized Follow-on Offering

Carbios website tombstone

Bryan, Garnier & Co advises Prosoft on its combination with personnel service software provider Landwehr, which is backed by growth technology investor Lea Partners

Prosoft_website_tombstone

Bryan, Garnier & Co acts as Sole Global Coordinator on a EUR 7.3 million Rights Issue for medtech company Pixium Vision

Pixium_website_tombstone

Bryan, Garnier & Co acts as Financial Advisor to Quilvest Capital Partners on its acquisition of Bretagne Télécom

Bretagne_Telecom_website_tombstone

Bryan, Garnier & Co acts as Sole Financial Advisor to the shareholders of Korta on the sale of the company to Rapyd

Korta_website_tombstone

Bryan, Garnier & Co acts as Sole Financial Advisor to Societe Generale on its acquisition of Shine

Shine_website_tombstone

Bryan, Garnier & Co advises Cathay Capital on its investment in FuturMaster

FuturMaster Tombstone

Bryan, Garnier & Co acts as Joint Global Coordinator and Joint Bookrunner on MedinCell’s Follow-on with top-tier European biotech specialists and institutional investors

Medincell_website_tombstone

Bryan, Garnier & Co acts as Sole Advisor to ECIT on the acquisition of 80% of IT-Hantverkarna Sverige AB (part of Fortner)

ECIT_website_tombstone

Bryan, Garnier & Co acts as Sole M&A and Strategic Advisor to BlueBee on its sale to Illumina

Bluebee_website_tombstone

Bryan, Garnier & Co acts as Sole Financial Advisor to Iris, part of the Canon Group, on the sale of their Hybrid Technology Solutions Division to Livia Group / Westpole

Canon_website_tombstone

Bryan, Garnier & Co acts as Sole Financial Advisor to Synergy Sky on the sale of a Minority Stake and Private Placement to RoosGruppen

Synergy-Sky_Tombstone

Bryan, Garnier & Co advises plant-based dairy alternative company Prolupin on its Capital Raise with Capricorn and NovAx

Prolupin_website_tombstone